Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
20.71
-0.63 (-2.95%)
Streaming Delayed Price
Updated: 2:00 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
HIMS Stock Rockets To Best Day Ever After Novo Nordisk Pact — Wall Street Upgrades Roll In As Shorts Lose $546M In One Day
↗
March 10, 2026
Short interest totalled about $1.39 billion, or roughly 42.83% of the float, according to S3 Partners.
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Stock Market Today, March 9: Hims & Hers Health Soars on Novo Nordisk Weight-Loss Drug Deal
↗
March 09, 2026
On March 9, 2026, a new Novo Nordisk pact reshaped this telehealth player’s GLP-1 strategy, margins, and legal risk profile.
Via
The Motley Fool
Topics
Intellectual Property
Lawsuit
Stocks
Top stock movements in today's session.
↗
March 09, 2026
Via
Chartmill
These stocks are making the most noise in today's session.
↗
March 09, 2026
Via
Chartmill
The Great 2026 Pivot: Tangible Assets Surge as Tech Giants Falter in Massive Sector Rotation
March 09, 2026
The financial landscape on March 9, 2026, has reached a critical tipping point, marking one of the most aggressive sector rotations in modern market history. As technology-heavy indices struggle to...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
March 09, 2026
Via
AB Newswire
Monday's session: top gainers and losers
↗
March 09, 2026
Via
Chartmill
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
March 09, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
↗
March 09, 2026
Hims & Hers stock traded more than 40% higher after the deal was announced.
Via
The Motley Fool
Topics
Lawsuit
Hims & Hers Stock Pops 40%: Everything You Need to Know
↗
March 09, 2026
Hims & Hers shares are up over 40% on Monday after announcing a deal with Novo Nordisk.
Via
The Motley Fool
Topics
Lawsuit
Why Hims & Hers Health (HIMS) Stock Is Up Today
March 09, 2026
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 41.7% in the morning session after the company announced a collaboration wi...
Via
StockStory
Topics
Economy
Lawsuit
Stocks
Gapping stocks in Monday's session
↗
March 09, 2026
Via
Chartmill
The Pivot to Legitimacy: Hims & Hers Health (HIMS) Faces a New Era of Personalized Medicine
March 09, 2026
Date: March 9, 2026Sector: Healthcare TechnologyCompany: Hims & Hers Health, Inc. (NYSE: HIMS) Introduction As of March 9, 2026, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself at perhaps the most...
Via
Finterra
Topics
Artificial Intelligence
Economy
Wondering what's happening in today's pre-market session?
↗
March 09, 2026
Via
Chartmill
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy
↗
March 09, 2026
Hims & Hers also stated that it will no longer advertise compounded GLP-1 offerings on its platform or in its marketing.
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Hims & Hers Announces Strategic Shift for US Weight Loss Business
March 09, 2026
From
Hims & Hers
Via
Business Wire
Oil Shock Sends Nasdaq, S&P 500 Futures Lower: Why USO, INDO, HIMS, NVDA Are On Traders' Radar Today
↗
March 09, 2026
Data from Stocktwits showed that retail sentiment on SPY and QQQ remains ‘bearish.’
Via
Stocktwits
Topics
ETFs
Economy
Government
HIMS Stock Could Rally Up To 60% This Week? Fund Manager Says He Wouldn’t Be ‘Surprised’ As Novo Nordisk Patch-Up Buzz Grows
↗
March 09, 2026
Lupton Capital CEO Jonah Lupton said the potential agreement could include both injectable and oral GLP-1 drugs.
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Novo Nordisk To Partner With Hims & Hers To Sell Weight-Loss Drugs: Report
↗
March 07, 2026
According to J.P. Morgan, the market for weight-loss drugs will become one of the biggest and fastest-growing in healthcare.
Via
Stocktwits
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Tariffs News & Market Chaos
↗
March 06, 2026
President Trump's tariffs have been overturned, throwing the market into even more chaos in 2026.
Via
The Motley Fool
Topics
Economy
Government
World Trade
HIMS Stock Rises Premarket: Investors Brush Off JPMorgan Stake Cut Amid FDA GLP-1 Crackdown
↗
March 06, 2026
The stake reduction comes as Hims navigates regulatory scrutiny over weight-loss drugs, while expanding into other healthcare categories.
Via
Stocktwits
Topics
Earnings
Lawsuit
The Compounding Cliff: Hims & Hers Faces Reckoning as FDA and Big Pharma Close GLP-1 Loopholes
March 04, 2026
NEW YORK — The era of easy access to compounded weight-loss "knockoffs" is rapidly drawing to a close, leaving the telehealth industry’s once-shining star, Hims & Hers Health, Inc. (NYSE: HIMS), in a...
Via
MarketMinute
Topics
Economy
Intellectual Property
Lawsuit
Hims Stock Slips Overnight As FDA Warns Telehealth Firms Over GLP-1 Claims — Why Traders Think The ‘Overhang’ Won’t Last
↗
March 04, 2026
The warnings involve compounded versions of Semaglutide, Tirzepatide and Liraglutide, the active ingredients in Wegovy, Ozempic and Mounjaro.
Via
Stocktwits
Topics
Lawsuit
Hims & Hers Finds A GLP-1 Hedge? HIMS Stock Rallies As RFK Jr. Signals Peptide Clearances
↗
March 03, 2026
The Futurum Group CEO Daniel Newman said Hims is the “most likely public company play” for peptides at scale.
Via
Stocktwits
Topics
Earnings
Supply Chain
What's Behind The Jump In Hims & Hers Health Stock?
↗
March 02, 2026
Shares of Hims & Hers Health, Inc. (NASDAQ: HIMS) are rising Monday after Secretary of Health and Human Services Robert F. Kennedy Jr. said on the Joe Rogan podcast that several peptide compounds, a...
Via
Benzinga
Unexpected Stock Picks and Looking to the Future
↗
March 02, 2026
Why does the shortest month of the year sometimes feel like the longest?
Via
The Motley Fool
Why I'm Not Worried About Novo Nordisk Stock
↗
March 02, 2026
The stock is down big of late, but the business is by no means doomed.
Via
The Motley Fool
Topics
Intellectual Property
Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
March 02, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
MarketBeat Week in Review – 02/23 - 02/27
↗
February 28, 2026
Sometimes the best offense is a good defense. That’s what investors seem to be feeling. Technology stocks continue to be under pressure, and that money is flowing into traditionally defensive assets...
Via
MarketBeat
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
February 27, 2026
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key...
Via
StockStory
Topics
Economy
Government
Stocks
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
